Recommendations In Clinical Guidelines, ‘No Benefit’ Ratings, And Opt-Out Decisions In Germany Since The Introduction Of The Amnog Law In 2011- How Do The Pieces Fit Together?
Abstract
Authors
TR Staab C Dintsios J Schulenburg J Ruof